SCOTTSDALE, AZ -- (MARKET WIRE) -- March 27, 2007 -- Medistem Laboratories, Inc. (OTCBB: MDSM) (FRANKFURT: S2U) announced today that it is collaborating with Dr. Hao Wang, researcher at Lawson Health Research Institute and Assistant Professor, Department of Surgery at The University of Western Ontario in London, Ontario, to conduct pre-clinical research on Medistem’s proprietary platform Tolerostem™. Subject to positive research results Medistem plans to submit an IND application to the FDA.
